RxDoctor Payments Data

Elizabeth Auyang, MD

Family Medicine · Gahanna, OHNPI 1700026069

Payments from drug & device makers

$905in general payments, 2019–2025

Across 40 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$163
  • Abbott$129
  • Novo Nordisk$76
  • Exact Sciences$54
  • Amgen$52
  • Pfizer$51
  • plus $380 from 13 others

What the payments were for

  • Food & beverage$905100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$905 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$34,043
Medicare patients
144
Services billed
461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$65,288
JanuviaSitagliptin Phosphate49$39,171
JardianceEmpagliflozin39$38,613
EliquisApixaban29$30,900
XareltoRivaroxaban14$22,460
TradjentaLinagliptin21$20,598
SavellaMilnacipran Hcl12$5,940
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,901
Atorvastatin Calcium298$2,835
Albuterol Sulfate HfaAlbuterol Sulfate58$2,704
Carbamazepine13$2,347
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen41$2,308
Levothyroxine Sodium228$2,285
Gabapentin58$2,103
FenofibrateFenofibrate,micronized54$1,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$76$65,28844 claims
MerckJanuvia$16$39,17149 claims
PfizerEliquis$51$30,90029 claims
AbbVieSavella, Synthroid$46$7,06752 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →